🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cancer Risk Factors

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study NCT07640048n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Adebrelimab, Gemcitabine, Cisplatin, S-1, Apatinib Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors NCT07095517Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Tirzepatide Night-shift Work and Breast Cancer NCT06786949n/a2 sites📍 Bologna📍 Messina IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Questionnaire, Blood samples for biomarker measurement Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV. A Randomized Controlled Crossover Study NCT07438080NA2 sites📍 Saint-Paul📍 Saint-Pierre Centre Hospitalier Universitaire de la Réunion · Tests: Public health workshop in community Factors Associated With Breast Cancer Risks and Outcomes NCT07294703n/a7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Survey A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis NCT07291141n/a1 site📍 Linköping Mattias Ekstedt Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks NCT05212454Phase 31 site📍 Hanzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Capecitabine MELIORA Data Collection Campaigns NCT07190066NA7 sites📍 Athens📍 Kaunas📍 Kaunas Harokopio University · Tests: Data Collection campaign CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors NCT06365671Phase 21 site📍 Shanghai Ruijin Hospital · Tests: autologous stem-cell transplantation, Relmacabtagene autoleucel (relma-cel) Pancreatic Cancer and Diabetes Mellitus NCT06585072n/a1 site📍 Shanghai Shanghai Changzheng Hospital · Tests: All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data. Using Middle School Science Teachers to Address Cancer Health Disparities NCT07501689NA5 sites📍 Brooklyn📍 New York📍 Queens Weill Medical College of Cornell University · Tests: CARES4You Curriculum Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer NCT06781762n/a1 site📍 Toronto University of Toronto · Tests: N/A (Usual Care) Incidence and Risk Factors of Post-Induction Hypotension in Geriatric Cancer Patients NCT07294040n/a1 site📍 Ankara Dolunay ARIK Risk Factors for Postoperative Cough in Patients Undergoing Thoracoscopic Lung Resection NCT06476249n/a1 site📍 Kunming Hematology department of the 920th hospital · Tests: without Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors NCT06727617Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Serplulimab, Chemotherapy, radiotherapy Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site📍 Durham Duke University Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification NCT06296732n/a1 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Duration of surgery intervention Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs NCT07136701n/a2 sites📍 Jinan📍 Jinan Qilu Hospital of Shandong University Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma NCT00040352n/a2 sites📍 Bethesda📍 Bethesda National Cancer Institute (NCI) Prospective Urban Rural Epidemiology Study NCT03225586n/a34 sites📍 Rosario📍 Dhaka📍 São Paulo Population Health Research Institute GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence NCT05557578Phase 22 sites📍 Hangzhou📍 Hanzhou Zhejiang Cancer Hospital · Tests: Tislelizumab combined with GEMOX (GOT) regimen Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV NCT06507917NA2 sites📍 Saint-Denis📍 Saint-Pierre Centre Hospitalier Universitaire de la Réunion · Tests: anal swabbing Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas NCT05851534NA13 sites📍 's-Hertogenbosch📍 Amsterdam📍 Amsterdam Maastricht University Medical Center · Tests: Preoperative optimisation program Hereditary Risk Factors for Thyroid Cancer NCT02747888NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: •Referral to Genetic Counselor, if indicated Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer NCT06889883n/a9 sites📍 Zaragoza📍 Bilbao📍 Donostia / San Sebastian ADVANCED MARKER DISCOVERY S.L. Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management. NCT07451483n/a1 site📍 Anderlecht Jules Bordet Institute Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients NCT07044427NA1 site📍 Heidelberg University Hospital Heidelberg · Tests: Strength and balance training in combination with a treadmill-based pertubation intervention Risk Factors for Neuroendocrine Neoplasms NCT06282016n/a1 site📍 Nuremberg Bavarian Cancer Registry · Tests: Case-control study (no intervention) Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer NCT05732623n/a8 sites📍 Denver📍 Chicago📍 Helsinki San Raffaele University · Tests: Semi Quantitative Food Frequency Questionnaire (SQFFQ) Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE NCT06607276Phase 24 sites📍 Nanjing📍 Nanjing📍 Xuzhou The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Adebrelimab and capecitabine, capecitabine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy